Article

US Preventive Services Task Force Reinforces 2015 Blood Pressure Screening Guidelines

The USPSTF recommendation reaffirms their 2015 stance, which calls for screening adults 18 years or older with office blood pressure measurement and obtaining measurements outside of a clinical setting for diagnostic confirmation before starting treatment.

This article was originally published on PracticalCardiology.com.

The US Preventive Services Task Force (USPSTF) is reaffirming the organization’s 2015 recommendation related to blood pressure screenings for adults in their latest recommendation statement.

The statement, which was published in JAMA, recommends screening adults 18 years or older with office blood pressure measurement and obtaining blood pressure measurements outside of a clinical setting for diagnostic confirmation before starting treatment. Further supporting their stance, the statement’s authors reported finding no new substantial evidence the could change its recommendation.

“Without screening, most people wouldn’t know they have hypertension and could be at risk for a heart attack or stroke,” said Task Force member John B. Wong, MD, of the Tufts Medical Center, in a statement. “Clinicians can improve their patients’ health by screening all adults for hypertension.”

Published in a separate article within JAMA, investigators also provide clinicians with the evidence base for their latest recommendation. To assess the benefits and harms of screening and confirmatory blood pressure measurements, the Task Force conducted a systematic review and meta-analysis of the information published within the MEDLINE, PubMed, Cochrane Collaboration Central Registry of Controlled Trials, and CINAHL databases through March 26, 2021.

Of note, the investigators' search included randomized clinical trials and nonrandomized controlled intervention studies for the effectiveness of screening and accuracy studies for screening and confirmatory measurements. Additionally, RCTs, nonrandomized controlled intervention studies, and observational studies were used for potential harms of screening and confirmation.


The statement, “Screening for Hypertension in Adults US Preventive Services Task Force Reaffirmation Recommendation Statement,” and supporting evidence, "Screening for Hypertension in Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force,” were published in JAMA.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.